Brand name development, INN/USAN name development, clinical trial naming, tagline development, corporate identity development
Brand positioning, brand assessment, brand messaging, brand architecture, nomenclature strategy, brand implementation
Logo development, brand standards, clinical trial design, package design, corporate identity development, identity and stationery systems
Name validation, logo validation, POCA, brand equity tracking, linguistic evaluation, medical panel evaluation, brand discovery/positioning research
Gaining regulatory approval is hard. And for every delay you encounter you are losing millions of dollars, which is why guidance through the complex regulatory landscape of drug naming demands a smart strategy. The Center for Regulatory Guidance ensures that we will always provide our clients with the latest and most accurate guidance in brand naming, non-proprietary naming and identity work.
Formerly with the FDA and EMA, CRG team members have been involved in the development of regulatory decisions and the very guidances that drive our work. Our team becomes your partner for regulatory submission.
Our in-house team always has the option to engage the vast Syneos Health network of regulatory experts and clinicians to deepen the therapeutic knowledge or broaden the understanding of local regulations.